EE371 Treatment Patterns, Healthcare Resource Use, and Costs Among US Patients With Epidermal Growth Factor Receptor Mutated (EGFRm) Metastatic Non-Small Cell Lung Cancer (mNSCLC) After Discontinuation of Osimertinib

Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.668
https://www.valueinhealthjournal.com/article/S1098-3015(24)00783-6/fulltext
Title : EE371 Treatment Patterns, Healthcare Resource Use, and Costs Among US Patients With Epidermal Growth Factor Receptor Mutated (EGFRm) Metastatic Non-Small Cell Lung Cancer (mNSCLC) After Discontinuation of Osimertinib
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00783-6&doi=10.1016/j.jval.2024.03.668
First page :
Section Title :
Open access? : No
Section Order : 10141
Categories :
Tags :
Regions :
ViH Article Tags :